Coronary atherosclerotic heart disease
Conditions
Interventions
Case series:no
Sponsors
The Seventh People's Hospital of Zhengzhou
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 80 years; 2.The duration of occlusion was more than 3 months; 3.The diameter of occluded vessels was more than or equal to 2.5mm; 4.Patients and their families refused surgical bypass surgery; 5.The subjects or their authorized family members voluntarily accepted the clinical trial and signed the written informed consent.
Exclusion criteria
Exclusion criteria: 1.Congenital heart disease, valvular heart disease, acute myocarditis, cardiomyopathy, pulmonary heart disease, bradyarrhythmia, such as atrioventricular block, sick sinus syndrome, etc; At the same time, they were complicated with malignant ventricular arrhythmias, such as persistent ventricular tachycardia; Patients with NYHA New York Heart function grade IV after standard treatment or left ventricular ejection fraction 700 x 10^9/L, white blood cell count < 3 x 10^9/L), Acute infectious diseases and autoimmune diseases; Malignant tumor, severe infection;, Severe nervous system diseases (severe disturbance of consciousness, severe nervous system infection, etc.), mental diseases (drug abuse, drug dependence, mental disorder can not cooperate) 4.The life expectancy is less than 12 months; 5. Pregnancy or planned pregnancy; 6.Aspirin, clopidogrel, ticagrelor and contrast media were intolerable; The patients could not tolerate dual antiplatelet therapy; 7.Participate in another drug or device study that has not yet reached the primary endpoint, or plan to participate in the clinical study within 12 months after the intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IVUS based assessment of late lumen loss at 1-year follow-up; | — |
Countries
China
Contacts
Public ContactZhao Yujie
The Seventh People's Hospital of Zhengzhou
Outcome results
None listed